(SYNSAM) Synsam - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0016829709
SYNSAM EPS (Earnings per Share)
SYNSAM Revenue
SYNSAM: Eyewear, Contact Lenses, Hearing Aids
Synsam AB is a leading player in the Nordic optical retail and eye health sector, operating a diverse portfolio of brands across multiple channels, including directly owned and franchised stores, as well as e-commerce platforms. The companys comprehensive product and service offerings cater to a wide range of customer needs, from corrective eyewear and contact lenses to hearing aids and related health services.
With a strong presence in Sweden, Denmark, Norway, Iceland, Faroe Islands, and Finland, Synsam AB has established itself as a significant market player, leveraging its extensive network of physical stores and online platforms to drive growth and customer engagement. The companys strategic brand portfolio, including Synsam, Profil Optik, and others, enables it to target different customer segments and stay competitive in a rapidly evolving market.
From a technical analysis perspective, Synsam ABs stock price has been trending near its 52-week high, with a current price of 48.25 SEK. The stock is trading below its 20-day simple moving average (SMA20) of 49.44 SEK, indicating a potential short-term correction. However, the stock remains above its 50-day SMA of 46.43 SEK and 200-day SMA of 45.46 SEK, suggesting a longer-term uptrend. The average true range (ATR) of 1.47 SEK, representing 3.04% of the current price, indicates moderate volatility.
Fundamentally, Synsam ABs market capitalization stands at approximately 7.3 billion SEK, with a price-to-earnings (P/E) ratio of 18.70, indicating a relatively reasonable valuation compared to its earnings. The companys return on equity (RoE) of 15.86% suggests a strong ability to generate profits from shareholder equity. Given these fundamental and technical indicators, a forecast for Synsam ABs stock could involve a potential short-term pullback towards the 46-47 SEK range, followed by a resumption of the longer-term uptrend, driven by the companys solid market position and growth prospects. A target price could be around 55-60 SEK in the next 6-12 months, based on the assumption of continued market share gains and expansion into new markets or services.
Additional Sources for SYNSAM Stock
SYNSAM Stock Overview
Market Cap in USD | 816m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception |
SYNSAM Stock Ratings
Growth Rating | -0.49 |
Fundamental | 66.3 |
Dividend Rating | 77.8 |
Rel. Strength | 12.3 |
Analysts | - |
Fair Price Momentum | 69.33 SEK |
Fair Price DCF | 91.19 SEK |
SYNSAM Dividends
Dividend Yield 12m | 34.61% |
Yield on Cost 5y | 36.91% |
Annual Growth 5y | 1.92% |
Payout Consistency | 98.8% |
Payout Ratio | 66.9% |
SYNSAM Growth Ratios
Growth Correlation 3m | 86% |
Growth Correlation 12m | 5.2% |
Growth Correlation 5y | -27.3% |
CAGR 5y | 3.68% |
CAGR/Max DD 5y | 0.07 |
Sharpe Ratio 12m | 0.27 |
Alpha | -6.60 |
Beta | 0.454 |
Volatility | 41.51% |
Current Volume | 295.4k |
Average Volume 20d | 279.7k |
As of July 01, 2025, the stock is trading at SEK 53.50 with a total of 295,413 shares traded.
Over the past week, the price has changed by +2.10%, over one month by +7.75%, over three months by +24.62% and over the past year by +6.19%.
Yes, based on ValueRay´s Fundamental Analyses, Synsam (ST:SYNSAM) is currently (July 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.26 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SYNSAM is around 69.33 SEK . This means that SYNSAM is currently undervalued and has a potential upside of +29.59% (Margin of Safety).
Synsam has no consensus analysts rating.
According to our own proprietary Forecast Model, SYNSAM Synsam will be worth about 75.8 in July 2026. The stock is currently trading at 53.50. This means that the stock has a potential upside of +41.68%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 66.3 | 24% |
Analysts Target Price | - | - |
ValueRay Target Price | 75.8 | 41.7% |